Geschäftstreiber: Bei West Pharmaceuticals handelt sich um einen Produzenten von Komponenten und Geräten für die Herstellung von Pharmazeutika, Biologika, Impfstoffen…
West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings…
…
KeyBanc maintains Overweight rating on West Pharmaceutical stock…
West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.…
LOS ANGELES, June 30, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming…
West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.…
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
The mean of analysts price targets for West Pharmaceutical (WST) points to a 26.9% upside in the stock. While this…
NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of…
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…
NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
West Pharmaceutical (WST) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Analyse der aktuellen Börsenperformance von West Pharmaceutical Services mit strategischer Neuausrichtung nach Beendigung wichtiger Kundenpartnerschaften. Die Aktie von West Pharmaceutical…
West Pharmaceutical (WST) delivered earnings and revenue surprises of 4% and 1.25%, respectively, for the quarter ended December 2024. Do…
West Pharmaceutical Services eyes fourth-quarter growth amid pharma stabilization, biologics rebound & contract manufacturing gains. Can WST sustain its momentum?…
…
…
WSTs third-quarter 2024 results are likely to reflect weakness in its Proprietary Products business. Unfavorable currency movements might have hurt…
Der Aktienkurs von West Pharmaceutical Services zeigt eine gemischte Performance. Am 19. Oktober 2024 verzeichnete die Aktie einen Anstieg von…
Die West Pharmaceutical Services Aktie zeigt sich kurz vor der Veröffentlichung des nächsten Quartalsberichts am 24. Oktober 2024 relativ stabil.…
Die West Pharmaceutical Services Aktie zeigt sich in einem volatilen Marktumfeld relativ stabil. Zum Handelsschluss am 22. September 2024 notierte…
West Pharmaceuticals (WST) second-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements…
The Global Closed System Transfer Devices Market Size was Valued at USD 1.3 Billion in 2023 and the Worldwide Closed…
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…
…
…
…
West Pharmaceuticals (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.…
West Pharmaceuticals (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements…
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…
An der US-amerikanischen Börse liegt die West Pharmaceutical Services-Aktie aktuell im Plus. Zuletzt zahlten Investoren für das Wertpapier 372,90 US-Dollar.…
Im Minus liegt zur Stunde die Aktie von West Pharmaceutical Services . Zuletzt zahlten Investoren für die Aktie 339,94 US-Dollar.…